Sfmg, LLC Gilead Sciences, Inc. Transaction History

Sfmg, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $2,812 - $3,207	-37 Reduced 1.16%	3,145 $242,000
Q1 2023 May 01, 2023	BUY	$77.31 - $88.08 $2,473 - $2,818	32 Added 1.02%	3,182 $264,000
Q4 2022 Jan 25, 2023	BUY	$62.32 - $89.47 $196,308 - $281,830	3,150 New	3,150 $0
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $33,362 - $37,575	578 Added 8.74%	7,191 $444,000
Q1 2022 Apr 21, 2022	SELL	$57.92 - $72.58 $39,038 - $48,918	-674 Reduced 9.25%	6,613 $393,000
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $472,780 - $536,614	7,287 New	7,287 $529,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

Stay updated on Sfmg, LLC with notifications on news.